Designating September 2025 as "Gynecologic Cancers Awareness Month".
- Bill Number
- H.Con.Res. 55
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-10-06: Referred to the House Committee on Energy and Commerce.
- Last Updated
- 2025-12-15T16:57:14Z
AI-Generated Summary
Purpose
This concurrent resolution (H. Con. Res. 55) aims to designate September 2025 as "Gynecologic Cancers Awareness Month." It highlights the importance of raising public awareness about gynecologic cancers—such as cervical, ovarian, endometrial/uterine, vaginal, and vulvar cancers—to promote early detection, prevention, and better health outcomes for women.
Key Provisions
- Background Facts: The resolution outlines key statistics and challenges, including:
- Approximately 118,920 new cases and 34,630 deaths from these cancers each year in the U.S.
- Endometrial cancer is one of the few cancers with increasing rates of new cases and deaths.
- Endometrial and ovarian cancers rank as the fifth and sixth leading causes of cancer deaths among women.
- Symptoms are often unclear or overlooked, with no routine screening tests for endometrial or ovarian cancers until later stages.
- Cervical cancer is the only one with a reliable screening test and can be prevented with vaccines.
- Congressional Support: Congress resolves to:
- Support the designation of September 2025 as Gynecologic Cancers Awareness Month.
- Endorse the goals of the month, including awareness efforts led by organizations like the Foundation for Women's Cancer.
- Affirm U.S. commitment to reducing the impact of these cancers by promoting awareness of causes, risks, and prevention; supporting research; and improving health outcomes to lower death rates.
- Encourage all Americans to learn about their personal risks for these cancers.
Significant Changes to Existing Law
This is a concurrent resolution, which is a non-binding expression of Congress's opinion and does not create new laws, amend existing statutes, or require funding. It introduces no changes to current legal frameworks but builds on ongoing public health initiatives related to cancer awareness and prevention.
Potential Impacts
- On Citizens: May increase public education and awareness, leading to earlier medical consultations, better prevention (e.g., through cervical cancer vaccines and screenings), and potentially fewer advanced-stage diagnoses. It encourages individuals, especially women, to discuss risks with healthcare providers.
- On Government Agencies: No direct mandates or funding; however, it could indirectly support agencies like the Centers for Disease Control and Prevention (CDC) or National Institutes of Health (NIH) in their cancer research and outreach efforts by signaling congressional priority.
- On International Relations: Minimal impact, as it focuses on domestic awareness; it may align with global health goals but does not address foreign policy.
Main Stakeholders Affected
- Women and Patients: Primary group at risk, benefiting from heightened awareness and potential improvements in diagnosis and treatment.
- Healthcare Professionals: Doctors, nurses, and researchers who may see increased patient inquiries and opportunities for education on screenings and prevention.
- Health Organizations: Groups like the Foundation for Women's Cancer, which lead awareness campaigns and could gain visibility and support for their initiatives.
- General Public: Encouraged to learn about risks, fostering broader societal support for women's health issues.
- Congress and Policymakers: Bipartisan sponsors (Rep. Dingell and Rep. Bacon) highlight cross-party interest in public health.
Notable Legal, Constitutional, or Political Implications
- Legal/Constitutional: As a symbolic resolution requiring agreement from both the House and Senate (but not presidential signature), it has no enforceable legal effect. It aligns with the Constitution's allowance for Congress to express views on public welfare without infringing on individual rights.
- Political: Demonstrates bipartisan commitment to women's health, potentially influencing future funding or legislation on cancer research. It promotes public health without controversy, emphasizing education over regulation, and could encourage similar designations for other awareness months.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-10-06: Referred to the House Committee on Energy and Commerce.
- 2025-10-06: Submitted in House
- 2025-10-06: Submitted in House
Bill Versions
- Designating September 2025 as "Gynecologic Cancers Awareness Month". — issued 2025-10-06 — PDF (3 pages)